Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Tvardi Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
No intraday reading yet this session.
TVRD (Tvardi Therapeutics, Inc.) has 1 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
57 institutional managers report a position in Tvardi Therapeutics, Inc. worth $4.2M between them, filed on form 13F for the quarter ending 2026-06-30. 9 of them hold 80% of it, the largest being Slate Path Capital LP at 31.61%.
32 more managers in the register
9 managers hold 80% of the $4.2M institutional base. The other 48 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via American Financial Group Inc, GSA Capital Partners LLP, Qube Research & Technologies Ltd · 10.04% of TVRD, 8.79% of CLPR
via American Financial Group Inc · 10.04% of TVRD, 19.43% of PFX
via Slate Path Capital LP, Qube Research & Technologies Ltd · 31.61% of TVRD, 5.45% of CLF
via Slate Path Capital LP · 31.61% of TVRD, 5.41% of WOLF
via Silvercrest Asset Management Group LLC, GSA Capital Partners LLP · 4.54% of TVRD, 6.48% of XGN
via Silvercrest Asset Management Group LLC, GSA Capital Partners LLP · 4.54% of TVRD, 4.58% of TSSI
Managers holding a meaningful stake in TVRD also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.